Procter & Gamble Health Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Jun ' 25	Mar ' 25	Jun ' 24	Jun ' 23	Jun ' 22

Sales

1,272.91

934.17

1,151.26

1,229.62

1,114.41

Operating profit

408.73

318.39

306.00

323.95

267.68

Interest

0.55

0.43

0.72

0.77

0.42

Gross profit

422.56

328.31

320.91

341.57

280.45

EPS (Rs)

181.08

141.21

121.07

138.23

115.98

Other income

14.38

10.35

15.63

18.39

13.19

Stock adjustment

24.89

14.75

0.87

2.85

-4.75

Raw material

260.13

200.59

290.23

319.23

323.72

Power and fuel

-

-

-

-

-

Employee expenses

198.07

142.06

215.16

206.17

167.56

Excise

-

-

-

-

-

Admin and selling expenses

-

-

-

-

-

Research and development expenses

-

-

-

-

-

Expenses capitalised

-

-

-

-

-

Other expenses

381.09

258.38

339.00

377.42

359.47

Provisions made

-

-

-

-

0.73

Depreciation

22.13

16.69

27.40

27.37

27.08

Taxation

99.84

77.21

72.34

84.73

60.85

Net profit / loss

300.59

234.41

200.98

229.47

192.52

Extra ordinary item

-

-

-20.19

-

-

Prior year adjustments

-

-

-

-

-

Equity capital

16.60

16.60

16.60

16.60

16.60

Equity dividend rate

-

-

-

-

-

Agg.of non-prom. shares (Lacs)

-

-

-

-

-

Agg.of non promotoholding (%)

-

-

-

-

-

OPM (%)

32.11

34.08

26.58

26.35

24.02

GPM (%)

32.83

34.76

27.50

27.37

24.87

NPM (%)

23.35

24.82

17.22

18.39

17.07